Peripheral nervous system specific sodium channels

Details Peripheral nervous system specific sodium channels Peripheral nervous system specific sodium channels

1999-12-09

2004-03-09

Kunz, Gary (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C930S010000

Reexamination Certificate

active

06703486

ABSTRACT:

FIELD OF THE INVENTION
The present invention is in the fields of biotechnology, protein purification and crystallization, x-ray diffraction analysis, three-dimensional computer molecular modeling, and rational drug design (RDD). The invention is directed to isolated peripheral nervous system (PNS) specific sodium channel proteins (SCPS) and encoding nucleic acid, as well as to compounds, compositions and methods for selecting, making and using therapeutic or diagnostic agents having sodium channel modulating activity. The present invention further provides three-dimensional computer modeling of the PNS SCP, and for RDD, based on the use of x-ray data and/or amino acid sequence data on computer readable media.
BACKGROUND OF THE INVENTION
Voltage-sensitive ion channels are a class of transmembrane proteins that provide a basis for cellular excitability, as the ability to transmit information via ion-generated membrane potentials. In response to changes in membrane potentials, these molecules mediate rapid ion flux through highly selective pores in a nerve cell membrane. If the channel density is high enough, a suitable regenerative depolarization results, termed the action potential.
The voltage-sensitive sodium channel is the ion channel most often responsible for generating the action potential in excitable cells. Although sodium-based action potentials in different excitable tissues look similar (Hille, B., In:
Ionic Channels of Excitable Membranes
, B. Hille, ed., Sinauer, Sunderland, Mass., (1984), pp. 70-71) recent electrophysiological studies indicate that sodium channels in different cells differ in both their structural and functional properties, and many sodium channels with distinct primary structures have now been identified. See, e.g. Mandel,
J. Membrane Biol.
125:193-205 (1992).
Functionally distinct sodium channels have been described in a variety of neuronal cell types (Llinas et al.,
J. Physiol.
305:197-213 (1980); Kostyuk et al.,
Neuroscience
6:2423-2430 (1981); Bossu et al.,
Neurosci. Lett.
51:241-246 (1984) 1981; Gilly et al.,
Nature
309:448-450 (1984); French et al.,
Neurosci. Lett.
56:289-294 (1985); Ikeda et al.,
J. Neurophysiol.
55:527-539 (1986); Jones et al.,
J. Physiol.
389:605-627 (1987); Alonso & Llinas, 1989; Gilly et al.,
J. Neurosci
9:1362-1374 (1989)) and in skeletal muscle (Gonoi et al.,
J. Neurosci.
5:2559-2564 (1985); Weiss et al.,
Science
233:361-364 (1986)). The kinetics of sodium currents in glia and neurons can also be distinguished (Barres et al.,
Neuron
2:1375-1388 (1989)).
The type II and type III genes, expressed widely in the central nervous system (CNS), are expressed at very low levels in some cells in the PNS (Beckh, S.,
FEBS Lett.
262:317-322 (1990)). The type II and III mRNAs were barely detectable, by Northern blot analysis, in dorsal root ganglion (DRG), cranial nerves and sciatic nerves. On the other hand, type I mRNA was present in moderately high amounts in DRG and cranial nerve, but in low levels in sciatic nerve. A comparison of the amount of all three brain mRNAs, relative to total sodium channel mRNA detected with a conserved cDNA probe, suggested the presence of additional, as yet unidentified, sodium channel types in DRG neurons. Consistent with the mRNA studies, immunochemical studies showed that neither type I nor type II sodium channel alpha subunits made up a significant component of the total sodium channels in the superior cervical ganglion or sciatic nerve (Gordon et al.,
Proc. Natl. Acad Sci. USA
84:8682-8686 (1987)).
A population of neurons in vertebrate DRG has been identified electrophysiologically that contains, in addition to the more conventional channels, a distinct sodium channel type; this DRG channel has a k
D
for tetradotoxin (TTX) approximately tenfold higher than the k
D
of sodium channels in either skeletal muscle or heart (Jones et al.,
J. Physiol.
389:605-627 (1987)).
The localization of different sodium channels to specific regions in the nervous system supports the possibility that cell-specific regulation of this gene family is at the transcriptional level. By analogy with other eukaryotic genes, distinct DNA elements can be present which mediate cell-specific and temporal regulation of individual sodium channel genes.
Studies of sodium channel gene regulation have been facilitated by the use of well-characterized cell lines, such as pheochromocytoma (PC12) cells, a popular cell model for neuronal differentiation (Green et al.,
Proc. Natl. Acad Sci. USA
73:2424-2428 (1976); Halegoua et al.,
Curr. Top. Microbiol. Immunol.
165:119-170 (1991)). In addition to extending neurites and initiating synthesis of certain neurotransmitters, NGF-treated PC 12 cells acquire the ability to generate sodium-based action potentials (Dichter et al.,
Nature
268:501-504 (1977)). This ability is conferred by an increase in the density of functional sodium channels in the membranes of the NGF-treated cells (Rudy et al.,
J. Neurosci.
7:1613-1625 (1987); Mandel et al.,
Proc. Natl. Acad. Sci. USA
85:924-928 (1988); O'Lague et al.,
Proc. Natl. Acad. Sci. USA
77:1701-1705 (1980)). Northern blot analysis revealed that undifferentiated PC12 cells contained a basal level of sodium channel mRNA which increased coincident with the increase in channel activity observed after treatment with NGF (Mandel et al.,
Proc. Natl. Acad. Sci. USA
85:924-928 (1988)).
There is a long standing need to diagnose and/or treat pathologies relating to impaired peripheral nervous system (PNS) nerve conduction associated with PNS injury or in genetic or other disease states, such as those involving lack of, or defects in, PNS sodium channels (SCs). In view of the possibility of cell or tissue specific sodium channels, the discovery and use of isolated PNS SCs and encoding nucleic acid would provide an opportunity to diagnose or treat such pathologies by either screening suitable PNS SC modulating drugs or molecules (e.g., analgesics), or by using recombinant PNS SCs for in situ or in vivo gene therapy to replace or supplement PNS SCs in at least one portion of the peripheral nervous system of a mammalian patient suffering from a PNS SC related pathology.
SUMMARY OF THE INVENTION
The present invention (hereinafter, “invention”) provides peripheral nervous system specific (PNS) sodium channel peptides (SCPs), encoding nucleic acid, vectors, host cells and antibodies, as well as methods of making and using thereof, including recombinant expression, purification, cell-based drug screening, gene therapy, crystallization, X-ray diffraction analysis, as well as computer structure determination and rational drug design utilizing at least one PNS SCP amino acid sequence and/or x-ray diffraction data provided on computer readable media.
The invention also includes oligonucleotide probes specific for PNS SCP encoding sequences, as well as methods for dectection in a sample, where the probe is labeled. The invention further includes methods for producing a PNS SCP, comprising culturing a host in a culture medium, comprising a PNS SCP nucleic acid; and isolating the PNS SCP from said host or said culture medium.
The invention additionally includes an antibody which binds an epitope specific for a PNS SCP, as well as host cells which express the antibody. Diagnostic or therapeutic methods using the antibody are also included in the invention.
The invention further includes gene therapy methods and delivery vectors comprising nucleic acid encoding, or complementary to, at least one PNS SCP, and pharmaceutically acceptable compositions thereof.
The invention also includes gene therapy by methods that administer an antisense PNS SCP nucleic acid to an animal in amount effective to provide a PNS SC modulating effect, such as an analgesic effect.
The present invention further provides methods for purifying and crystallizing a PNS SCP that can be analyzed to obtain x-ray diffraction patterns of sufficiently high resolution to be useful for three-dimensional molecular modeling of the protein. The x-ray diffraction

Affiliated with

Also associated with

Rating

Peripheral nervous system specific sodium channels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peripheral nervous system specific sodium channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peripheral nervous system specific sodium channels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3231320